ArticlePain and therapy2024

Changes in Use of Migraine Medications, Healthcare Resource Utilization, and Associated Direct Costs Over 12 Months Following Initiation of Erenumab: A US Retrospective Real-World Analysis.

Robert Urman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.